By 2030, the brain modalities and software market is on the path to produce $23,195.6 million from $13,343.3 million in 2021, growing at a 5.2% CAGR between 2021 and 2030. This is because of the increasing patient importance on effective and early disease diagnosis, growing cases of neurological ailments, and the surging need for safer and non-invasive medical imaging. For example, Alzheimer's Disease International estimates that 55 million individuals worldwide will have dementia by 2020. Furthermore, this number is predicted to rise to 78 million and 139 million by 2030 and 2050, respectively.
 |
| To learn more about this report: https://bit.ly/3EhuLu7 |
As the number of persons with non-communicable neurological illnesses increase, so does the amount spent on such treatment. Moreover, governments will confront a rising need for rehabilitation, support services, and neurological disorder treatment as the population increases. This is owing to the cases of significant debilitating neurological illnesses increases dramatically as people become older. Because most neurological disorders have few identifiable causes, more study is needed to create diagnostic, treatment, and preventative measures.
In the worldwide brain modalities and software market, the diagnostic imaging centers segment will increase at a CAGR of roughly 7% in the coming years. This is because, as compared to clinics, hospitals, and other facilities, diagnostic imaging centers provide more economical brain monitoring and imaging services. Shorter wait periods and more customized treatment are further benefits of approaching a standalone diagnostic clinic.
AI is progressively used to enhance diagnostic accurateness and image quality. Moreover, image excellence enhancement, ailment classification automation, and segmentation are all instances of AI advancements in imaging. Thus, advance AI technologies are available to support neurosurgeons in making treatment decisions and analyzing images. AI has evolved in popularity over the years, and now it is being used in brain scans to improve image quality, limit the period a patient spends inside an image scanner, and enhance decision-making of physician and clinical analysis.
APAC brain modalities and software market is the fastest growing region, which will to grow at a 7% CAGR in the coming years. Growing healthcare spending, the presence of a huge count of market players, increasing awareness of initial illness diagnosis through the use of sophisticated diagnostic imaging technologies, as well as the increasing incidence of brain ailments are boosting market in the area. The Radiology Asia 2019 conference, for example, was held in April 2019 in Singapore.
The use of neuroimaging methods such as PET–CT, CT, MRI, PET–MRI, and PET for detecting disorders linked to abnormalities and tumors has accepted over the years. Brain imaging methods are required at all phases of the process, from diagnosis via follow-ups until the end of the treatment cycle. These brain diagnostic devices are used for a variety of purposes, including determining the effects of cysts and tumors, stroke, and detecting edema and bleeding.
Hence, the demand for brain modalities and software will grow significantly, due to increasing patient emphasis on early and effective disease diagnosis.
